Innovation in Translational Science and Biomarkers

C-Path’s innovation in Translational Science and Biomarkers (iTSB) Program engages the organization’s biomarker core competency and the transformation of translational sciences. It supports existing, as well as emerging, initiatives in these scientific areas, throughout the organization. iTSB’s work may involve any therapeutic area and covers all aspects of drug development: from preclinical through translational efforts and, ultimately, clinical evaluation.